West Nile virus-associated meningoencephalitis in two chronically immunosuppressed renal transplant recipients

American Journal of Transplantation

Volumn 3, Issue 10, 2003, Pages 1312-1315

  Hardinger, Karen L ^a   Miller, Brent ^b   Storch, Gregory A ^b   Desai, Niraj M ^b   Brennan, Daniel C ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Encephalitis; Transplantation; West Nile virus

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMLODIPINE; AMPICILLIN; ATENOLOL; ATORVASTATIN; AZATHIOPRINE; CALCIUM CARBONATE; CEFEPIME; CEFTRIAXONE; COLCHICEINE; COLCHICINE; COTRIMOXAZOLE; GLIPIZIDE; IMMUNOGLOBULIN M ANTIBODY; ISOSORBIDE DINITRATE; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VANCOMYCIN;

ADULT; AGED; ARTICLE; CADAVER KIDNEY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MENINGOENCEPHALITIS; NONHUMAN; POSTOPERATIVE INFECTION; PYELONEPHRITIS; VIRUS MENINGITIS; WEST NILE FLAVIVIRUS;

ADULT; AGED; FLAVIVIRUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MENINGOENCEPHALITIS; WEST NILE VIRUS;

EID: 0141446289     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00223.x     Document Type: Article

References (13)

1. Smithburn KC, Hughes TP, Burke AW, Paul JH. Neurotopic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940; 20: 471-92.
2. Iwamoto M, Jernigan DB, Guasch A et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196-2203.
3. Petersen LR, Marflin AA. West Nile Virus: a primer for the clinician. Ann Intern Med 2002; 137: 173-179.
4. Serosurveys for West Nile Virus infection - New York and Connecticut counties, 2000. MMWR Morb Mortal Wkly Report 2001; 50: 37-39.
5. West Nile Virus Basics. Retrieved April 28, 2003 from http://www. cdc.gov/ncidood/dvbid/westnile/index.htm.
6. Epidemic/epizootic West Nile virus in the United States. Revised Guidelines for Surveillance, Prevention, and Control: from a Workshop Held in Charlotte, North Carolina, January 31-February 4, 2001. Fort Collins, Colorado: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Vector-Borne Infectious Diseases, 2001: 23.
7. Martin DA, Biggerstaff BJ, Allen B, Johnson AJ, Lanciotti RS, Roehrig JT. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 2002; 9: 544-549.
8. Hamdan A, Green P, Mendelson E et al. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 2002; 4: 160-162.
9. Shimoni Z, Niven MJ, Pitlick S, Bulvick S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 2001; 7: 759.
10. Monath TP, Arroyo J, Miller C, Guirakhoo F. West Nile virus vaccine. Curr Drug Targets Infect Disord 2001; 1: 37-50.
11. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8: 107-108.
12. Weiss D, Carr D, Kellachan J et al. Clinical findings of West Nile Virus infection in hospitalized patients, New York and New Jersey 2000. Emerg Infect Dis 2001; 7: 654-658.
13. Provisional Surveillance Summary of the West Nile Virus Epidemic. United States, January-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 833-836.